Skip to main content
$174.30 -$1.76 (-1.0%)

04:00 PM EST on 02/01/23

Moderna INC (NASDAQ:MRNA)

CAPS Rating: 3 out of 5

Current Price $174.30 Mkt Cap $67.6B
Open $174.70 P/E Ratio 5.90
Prev. Close $174.30 Div. (Yield) $0.00 (0.0%)
Daily Range $167.28 - $176.30 Volume 5,607,529
52-Wk Range $115.03 - $217.25 Avg. Daily Vol. 5,707,625

Caps

How do you think NASDAQ:MRNA will perform against the market?

Add Stock to CAPS Watchlist

All Players

343 Outperform
28 Underperform
 

All-Star Players

38 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:MRNA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

lemiwinx (60.80)
Submitted July 18, 2022

Covid is here to stay and so we will need vaccinations for the foreseeable future. mRNA tech has been proven and will be used to expand their pipelines to treat a wide range of diseases which will stabilize and expand their business.

Kelz74 (< 20)
Submitted September 28, 2021

Due to the fact that booster shots are not available to citizens under 65. Also, I believe that the majority of citizens willing to get a vaccine have already done so.

NASDAQ:MRNA Summary

Fools bullish on NASDAQ:MRNA are also bullish on:

Fools bearish on NASDAQ:MRNA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about MRNA.

Recs

0
Member Avatar pagliacci100 (41.73) Submitted: 1/18/2023 5:04:33 PM : Underperform Start Price: $188.83 NASDAQ:MRNA Score: +10.98

could be making a bottom? not inclined to take it long but this isn't working either

Recs

0
Member Avatar MFBriguy (99.97) Submitted: 1/11/2023 10:35:50 AM : Underperform Start Price: $186.43 NASDAQ:MRNA Score: +11.27

The Covid shots are failing. The current variants are vaccine-advantaged, meaning you are more vulnerable if you've had the shots than if you have not. The side effects are the worst in history. I believe demand for these shots and for MRNA overall will crater and that the political class in highly vaccinated countries will come after Pfizer and Moderna, remove their liability protections, and they will be subject to the most expensive product liability suits in history.

Recs

1
Member Avatar lemiwinx (60.80) Submitted: 7/18/2022 10:55:54 AM : Outperform Start Price: $157.25 NASDAQ:MRNA Score: +1.05

Covid is here to stay and so we will need vaccinations for the foreseeable future. mRNA tech has been proven and will be used to expand their pipelines to treat a wide range of diseases which will stabilize and expand their business.

Leaderboard

Find the members with the highest scoring picks in MRNA.

Score Leader

CMFSircc

CMFSircc (79.12) Score: +1,670.85

The Score Leader is the player with the highest score across all their picks in MRNA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
VermilionGS < 20 8/5/2019 Outperform 5Y $12.55 +1,288.84% +42.59% +1,246.26 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. farhangp < 20 10/14/2019 Outperform 5Y $14.19 +1,128.33% +38.65% +1,089.68 0 Comment
NextGenStock < 20 8/27/2019 Outperform 5Y $15.17 +1,048.98% +41.89% +1,007.09 0 Comment
IPO2019 < 20 9/9/2019 Outperform 5Y $16.00 +989.38% +37.85% +951.52 0 Comment
eagles777 70.23 2/13/2020 11/1/2022 Outperform 5Y $19.36 +800.31% +22.40% +777.91 0 Comment
syakita 53.21 11/22/2019 Outperform 5Y $19.98 +772.37% +32.05% +740.33 0 Comment
tortuga94 66.64 2/15/2019 Outperform 5Y $19.94 +774.12% +48.64% +725.48 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. stcksrus 77.52 1/27/2020 Outperform 5Y $21.57 +708.12% +26.75% +681.36 0 Comment
johnnyrocku 99.93 1/16/2020 Outperform 5Y $21.68 +703.97% +24.59% +679.37 0 Comment
stocksracer 72.99 3/5/2019 Outperform 5Y $21.18 +722.95% +46.95% +676.00 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MRNA.